Journey Medical Corp Stock In The News

DERM Stock  USD 5.25  0.09  1.69%   
Our overall analysis of Journey Medical's news coverage and content from conventional and social sources shows investors' bearish mood towards Journey Medical Corp. The specific impact of Journey Medical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Journey Medical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Journey Medical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Journey Medical Backtesting and Journey Medical Hype Analysis.

Journey Medical Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
https://www.globenewswire.com/news-release/2025/03/12/3041368/0/en/Journey-Medical-Corporation-to-Participate-in-the-37th-Annual-ROTH-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Journey Medical Corporation Announces Pu...
https://www.globenewswire.com/news-release/2025/03/05/3037745/0/en/Journey-Medical-Corporation-Announces-Publication-in-the-Journal-of-the-American-Medical-Association-Dermatology-of-the-Phase-3-Clinical-Trial-Results-of-Emrosi-DFD-29-to-Treat-Ros.html
 Neutral
Macroaxis News: globenewswire.com
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
https://www.globenewswire.com/news-release/2025/03/04/3036937/0/en/Journey-Medical-Corporation-to-Exhibit-at-the-2025-American-Academy-of-Dermatology-Annual-Meeting-in-Orlando-Florida.html
 Neutral
Macroaxis News: globenewswire.com
Journey Medical Corporation to Host Conf...
https://www.globenewswire.com/news-release/2025/01/23/3014281/0/en/Journey-Medical-Corporation-to-Host-Conference-Call-to-Discuss-U-S-Commercial-Launch-Plan-for-Emrosi-Minocycline-Hydrochloride-Extended-Release-Capsules-40-mg-for-the-Treatment-of-.html
 Neutral
Yahoo News
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
https://finance.yahoo.com/news/3-biotech-stocks-turn-5-162446975.html
 Bullish
Macroaxis News: globenewswire.com
Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
https://www.globenewswire.com/news-release/2023/11/14/2780529/28889/en/Fortress-Biotech-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Highlights.html
 Bullish
Macroaxis News: globenewswire.com
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
https://www.globenewswire.com/news-release/2023/11/07/2775557/0/en/Journey-Medical-Corporation-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Highlights.html
 Bullish
Macroaxis News: globenewswire.com
Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors
https://www.globenewswire.com/news-release/2023/11/01/2771092/0/en/Jasper-Therapeutics-Announces-Appointment-of-Thomas-G-Wiggans-as-Chairperson-of-the-Board-of-Directors.html
 Neutral
Macroaxis News: globenewswire.com
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
https://www.globenewswire.com/news-release/2023/10/31/2770196/0/en/Journey-Medical-Corporation-to-Announce-Third-Quarter-2023-Financial-Results-on-November-7-2023.html
 Bullish
Macroaxis News: globenewswire.com
Journey Medical Corporation Announces Da...
https://www.globenewswire.com/news-release/2023/10/20/2764004/0/en/Journey-Medical-Corporation-Announces-Data-from-Bioavailability-Study-of-DFD-29-Minocycline-Hydrochloride-Modified-Release-Capsules-40-mg-vs-Solodyn-Minocycline-Hydrochloride-Exten.html
 Neutral

Journey Medical Corp Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Journey and other traded companies coverage with news coverage. We help investors stay connected with Journey headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Journey Stock performance. Please note that trading solely based on the Journey Medical Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Journey Medical's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Journey Medical Corp investors visualize upcoming and past events in order to time the market based on Journey Medical Corp noise-free hype analysis.
Journey Medical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Journey earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Journey Medical that are available to investors today. That information is available publicly through Journey media outlets and privately through word of mouth or via Journey internal channels. However, regardless of the origin, that massive amount of Journey data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Journey Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Journey Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Journey Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Journey Medical alpha.

Journey Largest EPS Surprises

Earnings surprises can significantly impact Journey Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-06
2024-06-30-0.15-0.17-0.0213 
2024-11-13
2024-09-30-0.1475-0.120.027518 
2024-03-21
2023-12-31-0.08-0.12-0.0450 
2023-08-08
2023-06-30-0.33-0.290.0412 
2018-08-06
2018-06-30-0.51-0.57-0.0611 
2015-05-12
2015-03-31-0.65-0.570.0812 
View All Earnings Estimates

Journey Medical Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Journey Medical Corp Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Simply Wall St News at Macroaxis
12th of March 2025
Dont Ignore The Insider Selling In Journey Medical
at simplywall.st 
Google News at Macroaxis
10th of March 2025
Journey Medical CEO Claude Maraoui sells shares worth 203,451 - Investing.com India
at news.google.com 
Macroaxis News
7th of March 2025
Disposition of 14905 shares by Claude Maraoui of Journey Medical at 5.01 subject to Rule 1...
at MacroaxisInsider 
Macroaxis News: globenewswire.com
5th of March 2025
Disposition of 18147 shares by Claude Maraoui of Journey Medical at 5.13 subject to Rule 1...
at globenewswire.com 
Google News at Macroaxis
24th of February 2025
Journey Medical CFO Joseph Benesch sells 7,084 in stock - Investing.com India
at news.google.com 
Yahoo News
20th of February 2025
Journey Medical Corporation A Bull Case Theory
at finance.yahoo.com 
Yahoo News
4th of February 2025
PathAssist Derm Launches on AISight Advancing Dermatopathology Research Workflows using AI
at finance.yahoo.com 
Macroaxis News: globenewswire.com
23rd of January 2025
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan...
at globenewswire.com 
Yahoo News
16th of January 2025
By the numbers JJ, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Journey Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Journey Medical's short interest history, or implied volatility extrapolated from Journey Medical options trading.
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out Journey Medical Backtesting and Journey Medical Hype Analysis.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.